← Eichor
Condition: Minimal Change Disease Mcd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Minimal Change Disease Mcd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NEPTUNE Match Study
NA · 16 location(s) · University of Michigan · NCT04571658The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Phase N/A · 12 location(s) · Prof. Dr. Paul Brinkkoetter · NCT03949972Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2 · 47 location(s) · Travere Therapeutics, Inc. · NCT05003986Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)
Phase 2 · 6 location(s) · Medical University Innsbruck · NCT07710157A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
Phase 2/Phase 3 · 1 location(s) · Bio-Thera Solutions · NCT07499700Nephrotic Syndrome Study Network
Phase N/A · 44 location(s) · University of Michigan · NCT01209000Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinur
Phase 2 · 2 location(s) · Everest Medicines (China) Co.,Ltd. · NCT07614477A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Ye
Phase 2 · 71 location(s) · Sanofi · NCT06500702Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
Phase N/A · 1 location(s) · University of Michigan · NCT05650619
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.